StemCells, Inc. Posts Letter to Shareholders
May 29, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., May 29, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system, posted...
StemCells, Inc. Advances Clinical Trial in Age-Related Macular Degeneration to Final Cohort
May 22, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., May 22, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it has transplanted the Company's proprietary HuCNS-SC® (purified human neural stem cells)...
StemCells, Inc. Provides Update on Its Phase I/II Study in Spinal Cord Injury
May 19, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., May 19, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Armin Curt, M.D., study principal investigator, presented an interim update on the Phase I/II trial...
StemCells, Inc. Reports First Quarter 2014 Financial Results and Provides Business Update
May 14, 2014 16:00 ET
|
StemCells, Inc.
NEWARK, Calif., May 14, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Announces Webcast to Discuss First Quarter 2014 Financial Results
May 01, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., May 1, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Completes Enrollment in Spinal Cord Injury Trial
April 17, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., April 17, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it has completed enrollment in the Company's Phase I/II clinical trial in spinal cord injury. The...
StemCells, Inc. to Participate at the 13th Annual Needham Healthcare Conference
March 19, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., March 19, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that management will present at the 13th Annual Needham Healthcare Conference, on Wednesday, April 9,...
StemCells, Inc. Reports Fourth Quarter and Full Year 2013 Financial Results and Provides Business Update
March 12, 2014 15:30 ET
|
StemCells, Inc.
NEWARK, Calif., March 12, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. to Participate at 2014 Regen Med Investor Day in New York
March 10, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., March 10, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Martin McGlynn will present at the 2nd Annual Regen Med Investor Day, Wednesday, March 26, 2014,...
StemCells, Inc. Announces Webcast to Discuss Fourth Quarter and Full Year 2013 Financial Results
March 05, 2014 08:00 ET
|
StemCells, Inc.
NEWARK, Calif., March 5, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...